JOHNSON & JOHNSON — Director's Dealing 2007

Apr 6, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: eXegenics Inc (EXEG)
CIK: 0000944809
Period of Report: 2007-03-27

Reporting Person: JOHNSON & JOHNSON (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series C Preferred Stock	$0		Common Stock (12973600)		Indirect
Warrants to Purchase Common Stock	$.0193	2014-09-24	Common Stock (810849)		Indirect
Warrants to Purchase Common Stock	$.0193	2015-07-01	Common Stock (810848)		Indirect
Warrants to Purchase Common Stock	$.6728	2017-03-27	Common Stock (265489)		Indirect
Warrants to Purchase Common Stock	$.8473	2017-03-27	Common Stock (265489)		Indirect
Warrants to Purchase Common Stock	$1.0466	2017-03-27	Common Stock (265489)		Indirect
Stock Options (Right to Buy)	$.04	2007-09-27	Common Stock (5189)		Indirect
Stock Options (Right to Buy)	$.04	2007-09-27	Common Stock (25947)		Indirect
Stock Options (Right to Buy)	$.04	2007-09-27	Common Stock (103788)		Indirect
Stock Options (Right to Buy)	$.04	2007-09-27	Common Stock (5189)		Indirect
Stock Options (Right to Buy)	$.04	2007-09-27	Common Stock (155682)		Indirect

Footnotes

F1: The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the Reporting Person.

F2: There is no expiration date applicable to the Series C Preferred Stock.

F3: As of 3/27/07 vested as to 2,810 shares.

F4: As of 3/27/07 vested as to 56,218 shares.